The effect of casirivimab with imdevimab on disease progression in nonsevere COVID‐19 patients in a single hospital in Japan
Abstract Background Recent randomized trials have revealed that neutralizing monoclonal antibodies can reduce disease progression in mild–moderate COVID‐19 patients. However, no studies have investigated the effect of neutralizing monoclonal antibodies on clinical outcomes in Japan. Methods A single...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wiley
2022-05-01
|
| coleção: | Journal of General and Family Medicine |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1002/jgf2.516 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|